Chemoinformaics analysis of 3,7-DIHYDROXY-2-(4-HYDROXYPHENYL)CHROMEN-4-ONE
Molecular Weight | 270.24 | nRot | 1 |
Heavy Atom Molecular Weight | 260.16 | nRig | 0 |
Exact Molecular Weight | 270.053 | nRing | 3 |
Solubility: LogS | -6.657 | nHRing | 1 |
Solubility: LogP | 7.722 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 3 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 30 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
nHetero | 5 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
No. of Oxygen atom | 5 | No. of Arom Bond | 17 |
nHA | 5 | APOL | 35.7279 |
nHD | 3 | BPOL | 12.6361 |
QED | 0.315 |
Synth | 1.768 |
Natural Product Likeliness | 0.636 |
NR-PPAR-gamma | 0.397 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.937 |
HIA | 0.004 |
CACO-2 | -4.666 |
MDCK | 0.0000151 |
BBB | 0.064 |
PPB | 0.980315 |
VDSS | 2.015 |
FU | 0.0161342 |
CYP1A2-inh | 0.171 |
CYP1A2-sub | 0.195 |
CYP2c19-inh | 0.309 |
CYP2c19-sub | 0.06 |
CYP2c9-inh | 0.108 |
CYP2c9-sub | 0.956 |
CYP2d6-inh | 0.096 |
CYP2d6-sub | 0.05 |
CYP3a4-inh | 0.201 |
CYP3a4-sub | 0.04 |
CL | 6.227 |
T12 | 0.085 |
hERG | 0.289 |
Ames | 0.004 |
ROA | 0.017 |
SkinSen | 0.944 |
Carcinogencity | 0.031 |
EI | 0.974 |
Respiratory | 0.397 |
NR-Aromatase | 0.06 |
Antiviral | Yes |
Prediction | 0.780927 |